Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Evaluating analgesia: the challenges.

Henry J McQuay1, Jayne E Edwards, R Andrew Moore

  • 1Pain Research, Nuffield Department of Anesthetics, University of Oxford, The Churchill Oxford Radcliffe Hospital, Headington, UK. henry.mcquay@pru.ox.ac.uk

American Journal of Therapeutics
|April 10, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Glial-modulating agents for the treatment of pain: a systematic review.

Pain·2024
Same author

Ketamine for Cancer Pain: Re. Systematic Review by Jiao et al.

Journal of pain and symptom management·2024
Same author

Effectiveness of non-pharmacological interventions for fibromyalgia and quality of review methods: an overview of Cochrane Reviews.

Seminars in arthritis and rheumatism·2023
Same author

Trials We Cannot Trust: Investigating Their Impact on Systematic Reviews and Clinical Guidelines in Spinal Pain.

The journal of pain·2023
Same author

Characteristics of retracted publications related to pain research: a systematic review.

Pain·2023
Same author

Cannabis-based medicines and medical cannabis for adults with cancer pain.

The Cochrane database of systematic reviews·2023
Same journal

Abrocitinib as a Novel Therapeutic Option for Elastolytic Giant Cell Granuloma: A Case Report.

American journal of therapeutics·2026
Same journal

Dupilumab for Lichen Amyloidosis in an Elderly Multimorbid Patient.

American journal of therapeutics·2026
Same journal

Deucravacitinib for Generalized Pustular Psoriasis and Comorbid Polymyositis: Dual Efficacy and Favorable Safety.

American journal of therapeutics·2026
Same journal

Repurposed Drugs and Cardiovascular Morbidity: A Cost-Effectiveness Analysis.

American journal of therapeutics·2026
Same journal

Do Not Treat a Sequencing Report: Therapeutic Stewardship in Endometrial Microbiome Testing.

American journal of therapeutics·2026
Same journal

Right Side Accessory Pathway Mediated Cardiomyopathy Treated with Amiodarone: First Adult Case Report.

American journal of therapeutics·2026
See all related articles

Assessing pain relief medication efficacy requires high-quality trials. Larger patient numbers and specific metrics like number needed to treat enhance comparisons for analgesics.

Area of Science:

  • Pharmacology
  • Clinical Trials
  • Evidence-Based Medicine

Background:

  • Analgesic selection hinges on balancing efficacy and adverse effects.
  • Assessing analgesic efficacy is improving with clearer rules for systematic reviews and large clinical trials.
  • Challenges exist in evaluating over-the-counter (OTC) analgesics due to trial quality and dosage discrepancies.

Purpose of the Study:

  • To outline the principles for assessing analgesic efficacy and safety.
  • To highlight the importance of high-quality, large-scale clinical trials for reliable efficacy estimates.
  • To discuss the utility of metrics like Number Needed to Treat (NNT) and Number Needed to Harm (NNH) in comparative analyses.

Main Methods:

  • Systematic review and meta-analysis principles for efficacy assessment.

Related Experiment Videos

  • Critique of trial quality (randomization, blinding, sample size) in efficacy exaggeration.
  • Utilizing large datasets for dose-response, gender, and condition-specific analyses.
  • Exploring the role of patient experience databases for adverse effect evaluation.

    • Main Results:

    • High-quality trials with at least 500 patients provide credible efficacy estimates; more patients are needed for less effective drugs.
    • A meta-analysis indicated that 1000 mg paracetamol is more effective than 600-650 mg for moderate to severe postoperative pain.
    • Evidence-gathering rules for safety differ from efficacy, with patient experience databases potentially offering reliable data for adverse effects.

    Conclusions:

    • Rigorous methodology, including large patient numbers and appropriate metrics, is crucial for accurate analgesic efficacy assessment.
    • Paracetamol 1000 mg shows superior efficacy over lower doses in specific pain scenarios.
    • Further development of evidence-gathering rules for drug safety is needed, particularly utilizing patient-reported outcomes.